Home
NARI
NARI News

Latest Inari Medical Inc. (NARI) News on December 27, 2024

Argus Research

3 days ago

NARI: Lowering target price to $43.00

Inari Medical price target raised to $63 from $50 at Truist

TipRanks

8 days ago

Inari Medical price target raised to $63 from $50 at Truist

MT Newswires

8 days ago

Inari Medical Insider Sold Shares Worth $3,339,704, According to a Recent SEC Filing

MT Newswires

9 days ago

Truist Securities Raises Price Target on Inari Medical to $63 From $50, Keeps Hold Rating

Argus Research

9 days ago

NARI: Raising target price to $45.00

MT Newswires

10 days ago

Oppenheimer Initiates Coverage on Inari Medical With Outperform Rating, $75 Price Target

Inari Medical Stock Gets RS Rating Upgrade

Investor's Business Daily

15 days ago

Inari Medical Stock Gets RS Rating Upgrade

Argus Research

16 days ago

NARI: Raising target price to $44.00

Hologic (HOLX) Down 1.7% Since Last Earnings Report: Can It Rebound?

Zacks

23 days ago

Hologic (HOLX) Down 1.7% Since Last Earnings Report: Can It Rebound?

Reasons to Retain Inari Medical Stock in Your Portfolio for Now

Zacks

23 days ago

Reasons to Retain Inari Medical Stock in Your Portfolio for Now

Argus Research

23 days ago

NARI: What does Argus have to say about NARI?

NARI Stock Likely to Gain Following Reimbursement Approval in Japan

Zacks

24 days ago

NARI Stock Likely to Gain Following Reimbursement Approval in Japan

Inari Medical enters China distribution partnership

Medical Device Network

24 days ago

Inari Medical enters China distribution partnership

MT Newswires

24 days ago

Inari Medical Forms Joint Venture in Greater China

Inari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd.

GlobeNewswire

24 days ago

Inari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd.

Inari Medical Announces Joint Venture in Greater China

GlobeNewswire

24 days ago

Inari Medical Announces Joint Venture in Greater China

Why Is Penumbra (PEN) Up 6.7% Since Last Earnings Report?

Zacks

a month ago

Why Is Penumbra (PEN) Up 6.7% Since Last Earnings Report?

Argus Research

a month ago

NARI: What does Argus have to say about NARI?

MT Newswires

a month ago

Inari Medical Insider Sold Shares Worth $3,069,521, According to a Recent SEC Filing

Inside a $400 billion bet on the brain-computer interface revolution

Yahoo Finance

a month ago

Inside a $400 billion bet on the brain-computer interface revolution

Argus Research

a month ago

NARI: Raising target price to $41.00

Is Inari Medical (NARI) Trading at an Attractive Valuation?

Insider Monkey

2 months ago

Is Inari Medical (NARI) Trading at an Attractive Valuation?

Inari Medical to Participate in the Jefferies London Healthcare Conference

GlobeNewswire

2 months ago

Inari Medical to Participate in the Jefferies London Healthcare Conference

Argus Research

2 months ago

NARI: Raising target price to $40.00

MT Newswires

2 months ago

Inari Medical Insider Sold Shares Worth $2,002,000, According to a Recent SEC Filing

Edwards, Medtronic and Inari share trial data at TCT conference

MedTech Dive

2 months ago

Edwards, Medtronic and Inari share trial data at TCT conference

Inari Medical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

2 months ago

Inari Medical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Inari Medical Inc (NARI) Q3 2024 Earnings Call Highlights: Record Revenue and Raised Guidance ...

GuruFocus.com

2 months ago

Inari Medical Inc (NARI) Q3 2024 Earnings Call Highlights: Record Revenue and Raised Guidance ...

MT Newswires

2 months ago

Inari Medical's FlowTriever Outperforms Catheter-Directed Thrombolytics in Pulmonary Embolism Treatment; Shares Up

PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism

GlobeNewswire

2 months ago

PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism

Inari Medical Q3 Earnings Miss Estimates, Revenues Increase Y/Y

Zacks

2 months ago

Inari Medical Q3 Earnings Miss Estimates, Revenues Increase Y/Y

MT Newswires

2 months ago

Truist Raises Price Target on Inari Medical to $50 From $46, Keeps Hold Rating

Inari Medical, Inc. (NARI) Reports Q3 Loss, Tops Revenue Estimates

Zacks

2 months ago

Inari Medical, Inc. (NARI) Reports Q3 Loss, Tops Revenue Estimates

MT Newswires

2 months ago

Inari Medical Reports Q3 Loss, Higher Revenue; 2024 Sales Midpoint Guidance Boosted; Shares Rise

Inari Medical Reports Third Quarter 2024 Financial Results

GlobeNewswire

2 months ago

Inari Medical Reports Third Quarter 2024 Financial Results

Penumbra (PEN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks

2 months ago

Penumbra (PEN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Okami Medical Announces Closing Of $32.5M Financing

PR Newswire

2 months ago

Okami Medical Announces Closing Of $32.5M Financing

Analysts Estimate Inari Medical, Inc. (NARI) to Report a Decline in Earnings: What to Look Out for

Zacks

2 months ago

Analysts Estimate Inari Medical, Inc. (NARI) to Report a Decline in Earnings: What to Look Out for

Inari Medical Announces Partnership with AVF and NBCA on DEFIANCE Trial

GlobeNewswire

2 months ago

Inari Medical Announces Partnership with AVF and NBCA on DEFIANCE Trial

Inari Medical Inc (NARI) Q2 2024 Earnings Call Highlights: Record Revenue Growth Amidst Challenges

GuruFocus.com

3 months ago

Inari Medical Inc (NARI) Q2 2024 Earnings Call Highlights: Record Revenue Growth Amidst Challenges

Argus Research

3 months ago

NARI: Raising target price to $34.00

Inari Medical to Host Analyst and Investor Meeting Following PEERLESS RCT Presentation

GlobeNewswire

3 months ago

Inari Medical to Host Analyst and Investor Meeting Following PEERLESS RCT Presentation

Inari Medical to Announce Third Quarter 2024 Financial Results

GlobeNewswire

3 months ago

Inari Medical to Announce Third Quarter 2024 Financial Results

MT Newswires

3 months ago

Stifel Initiates Inari Medical at Hold With $50 Price Target

Reasons to Retain Inari Medical Stock in Your Portfolio for Now

Zacks

3 months ago

Reasons to Retain Inari Medical Stock in Your Portfolio for Now

MT Newswires

4 months ago

Leerink Partners Initiates Inari Medical at Market Perform

Inari Medical Announces PEERLESS Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2024

GlobeNewswire

4 months ago

Inari Medical Announces PEERLESS Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2024

Argus Research

4 months ago

NARI: Lowering target price to $35.00

Inari updates label of clot removal device linked to 6 deaths

MedTech Dive

4 months ago

Inari updates label of clot removal device linked to 6 deaths

FDA Classifies Recall Of Inari Medical's Large Vessel Clot Removal Catheter Device As Most Serious

Benzinga

4 months ago

FDA Classifies Recall Of Inari Medical's Large Vessel Clot Removal Catheter Device As Most Serious

Inari Medical (NARI) Issues Notice Post ClotTriever XL Recall

Zacks

4 months ago

Inari Medical (NARI) Issues Notice Post ClotTriever XL Recall

Inari Medical to Present at Upcoming Investor Conferences

GlobeNewswire

4 months ago

Inari Medical to Present at Upcoming Investor Conferences

Argus Research

4 months ago

NARI: Raising target price to $39.00

Director William Hoffman Sells 60,000 Shares of Inari Medical Inc (NARI)

GuruFocus.com

4 months ago

Director William Hoffman Sells 60,000 Shares of Inari Medical Inc (NARI)

The Inari Medical, Inc. (NASDAQ:NARI) Second-Quarter Results Are Out And Analysts Have Published New Forecasts

Simply Wall St.

5 months ago

The Inari Medical, Inc. (NASDAQ:NARI) Second-Quarter Results Are Out And Analysts Have Published New Forecasts

Inari promotes Kevin Strange to CFO

MedTech Dive

5 months ago

Inari promotes Kevin Strange to CFO

Inari Medical Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

5 months ago

Inari Medical Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Inari Medical (NARI) Q2 Earnings Miss, Revenues Increase Y/Y

Zacks

5 months ago

Inari Medical (NARI) Q2 Earnings Miss, Revenues Increase Y/Y

MT Newswires

5 months ago

Truist Adjusts Inari Medical's Price Target to $55 From $60, Maintains Hold Rating

MT Newswires

5 months ago

Inari Medical Q2 Swings to Loss, Raises 2024 Revenue Guidance; Appoints Kevin Strange CFO

Inari Medical, Inc. (NARI) Reports Q2 Loss, Tops Revenue Estimates

Zacks

5 months ago

Inari Medical, Inc. (NARI) Reports Q2 Loss, Tops Revenue Estimates

Inari Medical Announces Chief Financial Officer Retirement and Succession Plan

GlobeNewswire

5 months ago

Inari Medical Announces Chief Financial Officer Retirement and Succession Plan

Inari Medical Reports Second Quarter 2024 Financial Results

GlobeNewswire

5 months ago

Inari Medical Reports Second Quarter 2024 Financial Results

Is Now The Time To Look At Buying Inari Medical, Inc. (NASDAQ:NARI)?

Simply Wall St.

5 months ago

Is Now The Time To Look At Buying Inari Medical, Inc. (NASDAQ:NARI)?

MT Newswires

5 months ago

William Blair Starts Inari Medical With Outperform Rating

Glaukos (GKOS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks

5 months ago

Glaukos (GKOS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Argus Research

5 months ago

NARI: Lowering target price to $44.00

Inari Medical, Inc. (NARI) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Zacks

5 months ago

Inari Medical, Inc. (NARI) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Insider Sale: Chief Medical Officer Thomas Tu Sells Shares of Inari Medical Inc (NARI)

GuruFocus.com

5 months ago

Insider Sale: Chief Medical Officer Thomas Tu Sells Shares of Inari Medical Inc (NARI)

Director William Hoffman Sells 60,000 Shares of Inari Medical Inc (NARI)

GuruFocus.com

5 months ago

Director William Hoffman Sells 60,000 Shares of Inari Medical Inc (NARI)

MT Newswires

5 months ago

Inari Medical Insider Sold Shares Worth $3,404,646, According to a Recent SEC Filing

MT Newswires

5 months ago

Needham Downgrades Inari Medical to Hold From Buy

Argus Research

5 months ago

NARI: Raising target price to $46.00

Insider Sale: Chief Medical Officer Thomas Tu Sells Shares of Inari Medical Inc (NARI)

GuruFocus.com

5 months ago

Insider Sale: Chief Medical Officer Thomas Tu Sells Shares of Inari Medical Inc (NARI)

Inari Medical to Announce Second Quarter 2024 Financial Results

GlobeNewswire

5 months ago

Inari Medical to Announce Second Quarter 2024 Financial Results

MT Newswires

5 months ago

Truist Raises Price Target on Inari Medical to $60 From $47, Maintains Hold Rating

MT Newswires

5 months ago

Morgan Stanley Raises Price Target on Inari Medical to $60 From $55, Keeps Overweight Rating

Argus Research

6 months ago

NARI: Raising target price to $41.00

Here's Why You Should Retain Inari Medical (NARI) for Now

Zacks

6 months ago

Here's Why You Should Retain Inari Medical (NARI) for Now

Insider Sale: Director William Hoffman Sells 40,000 Shares of Inari Medical Inc (NARI)

GuruFocus.com

6 months ago

Insider Sale: Director William Hoffman Sells 40,000 Shares of Inari Medical Inc (NARI)

MT Newswires

6 months ago

Inari Medical Insider Sold Shares Worth $1,741,579, According to a Recent SEC Filing

A Look At The Intrinsic Value Of Inari Medical, Inc. (NASDAQ:NARI)

Simply Wall St.

6 months ago

A Look At The Intrinsic Value Of Inari Medical, Inc. (NASDAQ:NARI)

Italian energy company targets Britain for fleet of 20 mini-nukes

The Telegraph

7 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Motley Fool

7 months ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North

AFP

7 months ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

Simply Wall St.

7 months ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.

7 months ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Simply Wall St.

7 months ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

7 months ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled

Motley Fool

7 months ago

3 Mistakes That Can Get Your Costco Membership Canceled

Veracyte (VCYT) Up 8.4% Since Last Earnings Report: Can It Continue?

Zacks

7 months ago

Veracyte (VCYT) Up 8.4% Since Last Earnings Report: Can It Continue?

Inari's (NARI) Expanding Product Portfolio Offsets Competition

Zacks

7 months ago

Inari's (NARI) Expanding Product Portfolio Offsets Competition

Director William Hoffman Sells 60,000 Shares of Inari Medical Inc (NARI)

GuruFocus.com

7 months ago

Director William Hoffman Sells 60,000 Shares of Inari Medical Inc (NARI)

Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board

GlobeNewswire

7 months ago

Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board

Inari Medical (NARI) Sues Truvic on Patent Infringement

Zacks

7 months ago

Inari Medical (NARI) Sues Truvic on Patent Infringement

MT Newswires

7 months ago

Update: Inari Medical Sues Imperative Care, Truvic Medical for Alleged Patent Infringement

MT Newswires

7 months ago

Sector Update: Health Care Stocks Lower Thursday Afternoon

MT Newswires

7 months ago

Inari Medical Sues Imperative Care, Truvic Medical for Alleged Patent Infringement

Inari Medical Files Patent Infringement Lawsuit Against Imperative Care and Truvic Medical

GlobeNewswire

7 months ago

Inari Medical Files Patent Infringement Lawsuit Against Imperative Care and Truvic Medical

Here's Why You Should Retain Inari Medical (NARI) for Now

Zacks

7 months ago

Here's Why You Should Retain Inari Medical (NARI) for Now

Share on Social Networks: